Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.96
Delayed Data
As of Dec 08
 -0.08 / -1.32%
Today’s Change
2.80
Today|||52-Week Range
7.80
+18.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues5.8M6.8M9.3M6.3M
 
 
 
 
 
Cost of Goods Sold1.5M1.8M5.7M19.0M
 
 
 
 
 
Depreciation And Amortization165.0K261.0K259.0K256.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.1M4.8M3.3M-12.9M
 
 
 
 
 
General Expenses29.6M28.2M27.0M28.9M
 
 
 
 
 
Research And Development8.0M7.6M7.0M8.7M
 
 
 
 
 
Total Operating Expenses31.2M30.2M32.9M48.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.5M-23.4M-23.6M-41.8M
 
 
 
 
 
Extraordinary Charge0.00-2.0M-2.7M--
 
 
 
Interest Expense On Debt--15.7M18.5M0.00
 
 
 
Other Expenses-12.3M6.0K7.0K-19.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-37.8M-40.9M-44.6M-41.7M
 
 
 
 
 
Income Taxes-23.0K-20.0K-20.0K-20.0K
 
 
 
 
 
Net Income-37.8M-41.0M-44.7M-41.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS105.2M105.6M105.8M105.9M
 
 
 
 
 
Shares To Calculate EPS Diluted105.2M105.6M105.8M105.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.36-$0.39-$0.42-$0.39
 
 
 
 
 
EPS Diluted-$0.36-$0.39-$0.42-$0.39